Wei Li is the Executive Director of Clinical Business Operations at Organon, a position held since 2025. They previously served as the Sr. Director of Clinical Business Operations at Myovant Sciences from 2022 to 2023, and they have a rich background in clinical outsourcing and statistical programming, having worked for companies such as Genentech and Onyx Pharmaceuticals. Wei Li’s earlier career includes roles as a statistician at Indiana University Health and Response Oncology, and they hold a Master's degree from Virginia Tech and a Bachelor's degree from Hollins University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices